Artur Machlenkin
Chief Tech/Sci/R&D Officer at PLURI INC.
Profile
Artur Machlenkin is currently the Chief Scientific Officer at Pluri, Inc. He previously worked as the Chief Executive Officer at Pantheon Biosciences Ltd.
and as the Head-Immuno Oncology at Compugen Usa, Inc. Dr. Machlenkin holds a doctorate degree from the Weizmann Institute of Science.
Artur Machlenkin active positions
| Companies | Position | Start |
|---|---|---|
| PLURI INC. | Chief Tech/Sci/R&D Officer | 2022-04-30 |
Former positions of Artur Machlenkin
| Companies | Position | End |
|---|---|---|
| Compugen Usa, Inc. | Corporate Officer/Principal | - |
Pantheon Biosciences Ltd.
 Pantheon Biosciences Ltd. Miscellaneous Commercial ServicesCommercial Services Pantheon Biosciences Ltd. is an Israeli company that develops molecular therapies and tools. The company is based in Yavne, Israel and was founded in 2017. | Chief Executive Officer | - |
Training of Artur Machlenkin
| Weizmann Institute of Science | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| PLURI INC. | Health Technology |
| Private companies | 2 |
|---|---|
| Compugen Usa, Inc. | |
Pantheon Biosciences Ltd.
Pantheon Biosciences Ltd. Miscellaneous Commercial ServicesCommercial Services Pantheon Biosciences Ltd. is an Israeli company that develops molecular therapies and tools. The company is based in Yavne, Israel and was founded in 2017. | Commercial Services |
- Stock Market
- Insiders
- Artur Machlenkin
